| 複写 |  |
|---|---|
| 関連リンク |  |
| 出版者サイト |  |
文献
J-GLOBAL ID：200902226526510437
整理番号：05A0853612 ラット星状細胞におけるアセチル-L-カルニチン輸送の特徴
Characterization of acetyl-L-carnitine transport in rat astrocytes
クリップ引用文献 (32件)
- KERNER, J. Fatty acid import into mitochondria. Biochem Biophys Acta. 2000, 1486, 1-17
- PETTEGREW, JW. Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties : relevance for its mode of action in Alzheimer's disease and geriatric depression. Mol Psychiatry. 2000, 5, 616-632
- BIGINI, P. Acetyl-L-carnitine shows neuroprotective and neurotrophic activity in primary culture of rat embryo motoneurons. Neurosci Lett. 2002, 329, 334-338
- SHARMAN, EH. Reversal of biochemical and behavioral parameters of brain aging by melatonin and acetyl L-carnitine. Brain Res. 2002, 957, 223-230
- AURELI, T. Effect of acetyl-L-carnitine on recovery of brain phosphorus metabolites and lactic acid level during reperfusion after cerebral ischemia in the rat-study by 13P- and 1H-NMR spectroscopy. Brain Res. 1994, 643, 92-99
- ROSADINI, G. Acute effects of acetyl-L-carnitine on regional cerebral blood flow in patients with brain ischaemia. Int J Clin Pharmacol Res. 1990, 10, 123-128
- SPAGNOLI, A. Long-term acetyl-L-carnitine treatment in Alzheimer's disease. Neurology. 1991, 41, 1726-1732
- RAI, G. Double-blind, placebo controlled study of acetyl-L-carnitine in patients with Alzheimer's dementia. Curr Med Res Opin. 1990, 11, 637-647
- BONAVITA, E. Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain. Int J Clin Pharm Ther Toxicol. 1986, 24, 511-516
- SANO, M. Double-blind parallel design pilot study of acetyl levocarnitine inpatients with Alzheimer's disease. Arch Neurol. 1992, 49, 1137-1141
- KURATSUNE, H. Acylcarnitine deficiency in chronic fatigue syndrome. Clin Infect Dis. 1994, 18, S62-S67
- KURATSUNE, H. Low levels of serum acylcarnitine in chronic fatigue syndrome and chronic hepatitis type C, but not seen in other diseases. Int J Mol Med. 1998, 2, 51-56
- KURATSUNE, H. Brain Regions Involved in Fatigue Sensation : Reduced Acetylcarnitine Uptake into the Brain. NeuroImage. 2002, 17, 1256-1265
- PLIOPLYS, AV. Amantadine and L-carnitine treatment of Chronic Fatigue Syndrome. Neuropsychobiology. 1997, 35, 16-23
- TAMAI, I. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett. 1997, 419, 107-111
- TAMAI, I. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem. 1998, 273, 20378-20382
- TAMAI, I. Molecular and functional characterization of organic cation transporter. J Biol Chem. 2000, 275, 40064-40072
- YABUUCHI, H. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J Pharmacol Exp Ther. 1999, 289, 768-773
- WU, X. cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem Biophys Res Commun. 1998, 246, 589-595
- WU, X. Functional characteristics and tissue distribution pattern of organic cationtransporter 2 (OCTN2), an organic cation/carnitine transporter. J. Pharmacol. Exp. Ther. 1999, 290, 1482-1492
前のページに戻る
